Comprehensive Analysis of Prognostic Microenvironment-Related Genes in Invasive Breast Cancer

被引：5

作者：

Shi, Yingrong ^{[1
]}

Chen, Si ^{[1
]}

Xing, Huijuan ^{[1
]}

Jiang, Guanglie ^{[1
]}

Wu, Nan ^{[1
]}

Liu, Qiannan ^{[1
]}

Sakamoto, Norihiro ^{[2
]}

Kuno, Takayoshi ^{[1
,2
]}

Sugiura, Reiko ^{[3
]}

Xiao, Qinghuan ^{[4
]}

Jin, Feng ^{[5
]}

Fang, Yue ^{[1
]}

Yao, Fan ^{[5
]}

机构：

[1] China Med Univ, Sch Pharm, Dept Microbial & Biochem Pharm, Shenyang, Peoples R China

[2] Kobe Univ, Grad Sch Med, Div Food & Drug Evaluat Sci, Kobe, Japan

[3] Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogen, Higashiosaka, Osaka, Japan

[4] China Med Univ, Sch Pharm, Dept Ion Channel Pharmacol, Shenyang, Peoples R China

[5] China Med Univ, Affiliated Hosp 1, Res Unit Gen Surg, Dept Breast Surg & Surg Oncol, Shenyang, Peoples R China

来源：

FRONTIERS IN ONCOLOGY | 2022年 / 11卷

基金：

中国国家自然科学基金;

关键词：

invasive breast cancer; TCGA database; prognosis; SASH3; immune; stromal; ESTIMATE score; tumor microenvironment; SUPPRESSOR SASH1 INTERACTS; DOWN-REGULATION; EXPRESSION; ASSOCIATION; LYMPHOCYTES; METASTASIS; ACTIVATION; CHEMOKINES; RECEPTORS; GROWTH;

D O I：

10.3389/fonc.2021.576911

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Recent studies reveal that tumor microenvironment contributes to breast cancer (BRCA) development, progression, and therapeutic response. However, the contribution of the tumor microenvironment-related genes in routine diagnostic testing or therapeutic decision making for BRCA remains elusive. Immune/stromal/ESTIMATE scores calculated by the ESTIMATE algorithm quantify immune and stromal components in a tumor, and thus can reflect tumor microenvironment. To investigate the association of the tumor microenvironment-related genes with invasive BRCA prognosis, here we analyzed the immune/stromal/ESTIMATE scores in combination with The Cancer Genome Atlas (TCGA) database in invasive BRCA. We found that immune/stromal/ESTIMATE scores were significantly correlated with the invasive BRCA clinicopathological factors. Based on the immune/stromal/ESTIMATE scores, we extracted a series of differential expression genes (DEGs) related to the tumor microenvironment. Survival analysis was further performed to identify a list of high-frequency DEGs (HF-DEGs), which exhibited prognostic value in invasive BRCA. Importantly, consistent with the results of bioinformatics analysis, immunohistochemistry results showed that high SASH3 expression was associated with a good prognosis in invasive BRCA patients. Our findings suggest that the tumor microenvironment-related HF-DEGs identified in this study have prognostic values and may serve as potential biomarkers and therapeutic targets for invasive BRCA.

引用

页数：13

共 47 条

[1] Breast cancer in young women: an overview [J].

Anastasiadi, Zoi ;

Lianos, Georgios D. ;

Ignatiadou, Eleftheria ;

Harissis, Haralampos V. ;

Mitsis, Michail .

UPDATES IN SURGERY, 2017, 69 (03) :313-317

[2] CXC chemokines located in the 4q21 region are up-regulated in breast cancer [J].

Bieche, Ivan ;

Chavey, Carine ;

Andrieu, Catherine ;

Busson, Muriel ;

Vacher, Sophie ;

Le Corre, Ludovic ;

Guinebretiere, Jean-Marc ;

Burlinchon, Sandrine ;

Lidereau, Rosette ;

Lazennec, Gwendal .

[3] HACS1 encodes a novel SM-SAM adaptor protein differentially expressed in normal and malignant hematopoietic cells [J].

Claudio, J ;

Zhu, YX ;

Benn, SJ ;

Shukla, AH ;

McGlade, CJ ;

Falcioni, N ;

Stewart, AK .

ONCOGENE, 2001, 20 (38) :5373-5377

[4]

Coventry BJ, 1996, J IMMUNOL, V156, P3486

[5] Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1 [J].

Coyle, Krysta M. ;

Murphy, J. Patrick ;

Vidovic, Dejan ;

Vaghar-Kashani, Ahmad ;

Dean, Cheryl A. ;

Sultan, Mohammad ;

Clements, Derek ;

Wallace, Melissa ;

Thomas, Margaret L. ;

Hundert, Amos ;

Giacomantonio, Carman A. ;

Helyer, Lucy ;

Gujar, Shashi A. ;

Lee, Patrick W. K. ;

Weaver, Ian C. G. ;

Marcato, Paola .

ONCOTARGET, 2016, 7 (28) :44096-44112

[6] SASH3 variants cause a novel form of X-linked combined immunodeficiency with immune dysregulation [J].

Delmonte, Ottavia M. ;

Bergerson, Jenna R. E. ;

Kawai, Tomoki ;

Kuehn, Hye Sun ;

McDermott, David H. ;

Cortese, Irene ;

Zimmermann, Michael T. ;

Dobbs, A. Kerry ;

Bosticardo, Marita ;

Fink, Danielle ;

Majumdar, Shamik ;

Palterer, Boaz ;

Pala, Francesca ;

Dsouza, Nikita R. ;

Pouzolles, Marie ;

Taylor, Naomi ;

Calvo, Katherine R. ;

Daley, Stephen R. ;

Velez, Daniel ;

Agharahimi, Anahita ;

Myint-Hpu, Katherine ;

Dropulic, Lesia K. ;

Lyons, Jonathan J. ;

Holland, Steven M. ;

Freeman, Alexandra F. ;

Ghosh, Rajarshi ;

Similuk, Morgan B. ;

Niemela, Julie E. ;

Stoddard, Jennifer ;

Kuhns, Douglas B. ;

Urrutia, Raul ;

Rosenzweig, Sergio D. ;

Walkiewicz, Magdalena A. ;

Murphy, Philip M. ;

Notarangelo, Luigi D. .

BLOOD, 2021, 138 (12) :1019-1033

[7] Web-TCGA: an online platform for integrated analysis of molecular cancer data sets [J].

Deng, Mario ;

Braegelmann, Johannes ;

Schultze, Joachim L. ;

Perner, Sven .

BMC BIOINFORMATICS, 2016, 17

[8] Estrogen Induces Vav1 Expression in Human Breast Cancer Cells [J].

Du, Ming-juan ;

Chen, Xiang-dong ;

Zhou, Xiao-li ;

Wan, Ya-juan ;

Lan, Bei ;

Zhang, Cui-zhu ;

Cao, Youjia .

PLOS ONE, 2014, 9 (06)

[9] A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis [J].

Eifert, Cheryl ;

Wang, Xianhui ;

Kokabee, Leila ;

Kourtidis, Antonis ;

Jain, Ritu ;

Gerdes, Michael J. ;

Conklin, Douglas S. .

GENES CHROMOSOMES & CANCER, 2013, 52 (10) :961-975

[10] Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II [J].

Feigelson, Heather Spencer ;

Teras, Lauren R. ;

Diver, W. Ryan ;

Tang, Weining ;

Patel, Alpa V. ;

Stevens, Victoria L. ;

Calle, Eugenia E. ;

Thun, Michael J. ;

Bouzyk, Mark .

BREAST CANCER RESEARCH, 2008, 10 (04)

← 1 2 3 4 5 →